Patents by Inventor Ping-Ying Pan

Ping-Ying Pan has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Anti-LILRB3 antibodies and methods of use thereof
    Patent number: 11787858
    Abstract: Antibodies and antibody fragments that specifically bind to LILRB3 are disclosed. Also provided herein are compositions comprising antibodies and antibody fragments that specifically bind to LILRB3 and methods of use thereof.
    Type: Grant
    Filed: December 22, 2017
    Date of Patent: October 17, 2023
    Assignee: Icahn School of Medicine at Mount Sinai
    Inventors: Shu-Hsia Chen, Ping-Ying Pan
  • ANTI-LILRB2 ANTIBODIES AND METHODS OF USE THEREOF
    Publication number: 20220056128
    Abstract: Antibodies and antibody fragments that specifically bind to LILRB2 are disclosed. Also provided herein are compositions comprising antibodies and antibody fragments that specifically bind to LILRB2 and methods of use thereof. Also provided are related chimeric antigen receptors (CARs) and cells comprising same (e.g., T cells, natural killer cells, or macrophages), and uses of the CARs and cells in targeting tumors and killing them, asthma treatment, or in targeting and removing infected cells (e.g., to treat infections or infectious diseases), or in suppressing immune system cells, as involved in autoimmune disease or transplant rejection.
    Type: Application
    Filed: September 17, 2019
    Publication date: February 24, 2022
    Inventors: Shu-Hsia Chen, Ping-Ying Pan
  • ANTI-LILRB3 ANTIBODIES AND METHODS OF USE THEREOF
    Publication number: 20200071398
    Abstract: Antibodies and antibody fragments that specifically bind to LILRB3 are disclosed. Also provided herein are compositions comprising antibodies and antibody fragments that specifically bind to LILRB3 and methods of use thereof.
    Type: Application
    Filed: December 22, 2017
    Publication date: March 5, 2020
    Inventors: Shu-Hsia Chen, Ping-Ying Pan, Hui-ming Chen, William van der Touw
  • In Vitro Generation of Myeloid Derived Suppressor Cells
    Publication number: 20120082688
    Abstract: The invention relates to methods of isolating, culturing, and differentiating myeloid derived suppressor cells (MD-SCs) from embryonic stem (ES) cells and hematopoietic stem cells (HSCs). In certain embodiments, the invention relates to methods and compositions for producing MDSCs from ES cells and HSCs using a combination of factors including macrophage colony-stimulating factor (M-CSF).
    Type: Application
    Filed: November 25, 2009
    Publication date: April 5, 2012
    Applicant: MOUNT SINAI SCHOOL OF MEDICINE
    Inventors: Shu-Hsia Chen, Zuping Zhou, Ping-Ying Pan